Measuring spend instead of comprehensive program value Many employers track pharmacy costs closely
Grosse: nothing to disclose, Johanna Ernst: nothing to disclose Poster Session II - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.02 - GENETICS, OMICS AND BIOMARKERS P1056 - ESOC25-766 REGULATORY AUTOANTIBODIES AND CLINICAL OUTCOME AFTER ISCHEMIC STROKE (PROSCIS-B) Anna-Sophia Miesenberger 1,2 , Pia Sophie Sperber 1,2,3 , Friederike Antonia Arlt 2,4 , Pimrapat Gebert 5 , Harald Heidecke 6 , Guido Moll 7,8,9 , Rusan Ali Catar 7 , Leif Koschtzke 1,2 , Christoph Harms 1,2 , Anna Kufner 1,2 , Thomas Liman 1,2,4 , Matthias Endres 1,2,4 1 Center for Stroke Research Berlin (CSB), Berlin, Charit - Universittsmedizin Berlin, corporate member of Freie Universitt Berlin and Humboldt-Universitt zu Berlin, Berlin, Germany, 2 Department of Neurology and Experimental Neurology, Charit-Universittsmedizin Berlin, Corporate Member of Freie Universitt Berlin, Humboldt-Universitt Berlin, Berlin, Germany, 3 Experimental and Clinical Research Center, a Cooperation Between Max Delbrck Center for Molecular Medicine in the Helmholtz Association, Charit Universittsmedizin Berlin, Geschftsfhrung, Charitplatz 1, 10117 Berlin, Germany, Berlin, Germany, 4 German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany, 5 Institute of Biometry and Clinical Epidemiology, Charit-Universittsmedizin Berlin, Corporate member of Freie Universitt and Humboldt-Universitt zu Berlin, Berlin, Germany, 6 CellTrend GmBH, Luckenwalde, Germany, 7 Department of Nephrology and Internal Intensive Care Medicine, Charit-Universittsmedizin Berlin, Corporate member of Freie Universitt and Humboldt-Universitt zu Berlin, Berlin, Germany, 8 BIH Center for Regenerative Therapies (BCRT), Berlin, Germany, 9 Julius Wolff Institute for Musculoskeletal Research (JWI), Berlin, Germany Background and Aims: The relevance of GPCR-directed regulatory autoantibodies (RABs) in stroke is unclear
Bottom line, its never been easier to lose weight and keep it off by using our personal, medically-based treatment plans now with the option of adding the most powerful and effective weight loss medications ever approved by the FDA
Abstract Kidney stone is a common and highly recurrent disease in urology, and its pathogenesis is associated with various factors
The National Institutes of Health reports that zinc deficiency can lead to hair loss, slowed growth, and poor wound healing
There are two specific immunoglobulin-like membrane-bound IL-1 receptors, IL-1RI and IL-1RII
